Manoj Kumar Mahapatra

479 total citations
16 papers, 368 citations indexed

About

Manoj Kumar Mahapatra is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Manoj Kumar Mahapatra has authored 16 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 8 papers in Molecular Biology and 5 papers in Toxicology. Recurrent topics in Manoj Kumar Mahapatra's work include Synthesis and biological activity (7 papers), Protein Tyrosine Phosphatases (6 papers) and Bioactive Compounds and Antitumor Agents (5 papers). Manoj Kumar Mahapatra is often cited by papers focused on Synthesis and biological activity (7 papers), Protein Tyrosine Phosphatases (6 papers) and Bioactive Compounds and Antitumor Agents (5 papers). Manoj Kumar Mahapatra collaborates with scholars based in India, Saudi Arabia and United States. Manoj Kumar Mahapatra's co-authors include Rajnish Kumar, Manoj Kumar, Biswa Mohan Sahoo, Bimal Krishna Banik, Preetismita Borah, Krishnendu Bera, Ankit Uniyal, Manoj Kumar, Durg Vijay Singh and Rajat Sandhir and has published in prestigious journals such as Molecules, Bioorganic & Medicinal Chemistry and Medicinal Research Reviews.

In The Last Decade

Manoj Kumar Mahapatra

16 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manoj Kumar Mahapatra India 10 171 144 98 40 39 16 368
Biswajit Kundu India 10 151 0.9× 224 1.6× 96 1.0× 31 0.8× 32 0.8× 17 411
Abdeen Tunde Ogunlana Nigeria 9 103 0.6× 212 1.5× 169 1.7× 28 0.7× 25 0.6× 19 413
Abdul-Quddus Kehinde Oyedele Nigeria 9 101 0.6× 200 1.4× 168 1.7× 26 0.7× 22 0.6× 14 391
Ekta Rathi India 13 166 1.0× 201 1.4× 124 1.3× 35 0.9× 27 0.7× 25 416
Noor Atatreh United Arab Emirates 12 166 1.0× 169 1.2× 116 1.2× 39 1.0× 38 1.0× 33 397
T. Ngoc Han Pham Vietnam 5 88 0.5× 191 1.3× 164 1.7× 37 0.9× 23 0.6× 8 404
Amit Bhattacharya India 11 260 1.5× 163 1.1× 67 0.7× 34 0.8× 14 0.4× 17 533
Ravi Rawat India 11 127 0.7× 103 0.7× 81 0.8× 24 0.6× 12 0.3× 40 310
Alexios N. Matralis Greece 16 216 1.3× 316 2.2× 93 0.9× 24 0.6× 12 0.3× 29 559
Faheem Faheem India 9 241 1.4× 147 1.0× 118 1.2× 73 1.8× 10 0.3× 21 446

Countries citing papers authored by Manoj Kumar Mahapatra

Since Specialization
Citations

This map shows the geographic impact of Manoj Kumar Mahapatra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manoj Kumar Mahapatra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manoj Kumar Mahapatra more than expected).

Fields of papers citing papers by Manoj Kumar Mahapatra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manoj Kumar Mahapatra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manoj Kumar Mahapatra. The network helps show where Manoj Kumar Mahapatra may publish in the future.

Co-authorship network of co-authors of Manoj Kumar Mahapatra

This figure shows the co-authorship network connecting the top 25 collaborators of Manoj Kumar Mahapatra. A scholar is included among the top collaborators of Manoj Kumar Mahapatra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manoj Kumar Mahapatra. Manoj Kumar Mahapatra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sahoo, Biswa Mohan, et al.. (2021). Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection. Frontiers in Molecular Biosciences. 8. 628144–628144. 91 indexed citations
2.
Mahapatra, Manoj Kumar, et al.. (2021). Synthesis and Anti-hyperglycaemic Study of Aryl Sulfonate Ester Conjugated 5-arylidene-thiazolidine-2,4-diones. Indian Journal of Pharmaceutical Education and Research. 55(3). 894–903. 5 indexed citations
3.
Banik, Bimal Krishna, et al.. (2021). Green Synthetic Approach: An Efficient Eco-Friendly Tool for Synthesis of Biologically Active Oxadiazole Derivatives. Molecules. 26(4). 1163–1163. 32 indexed citations
4.
Uniyal, Ankit, Manoj Kumar Mahapatra, Vinod K. Tiwari, Rajat Sandhir, & Rajnish Kumar. (2020). Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors. Journal of Biomolecular Structure and Dynamics. 40(8). 3609–3625. 33 indexed citations
5.
Mahapatra, Manoj Kumar, Rajnish Kumar, & Manoj Kumar. (2017). Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors. Bioorganic Chemistry. 71. 1–9. 29 indexed citations
6.
Mahapatra, Manoj Kumar, Krishnendu Bera, Durg Vijay Singh, Rajnish Kumar, & Manoj Kumar. (2017). In silico modelling and molecular dynamics simulation studies of thiazolidine based PTP1B inhibitors. Journal of Biomolecular Structure and Dynamics. 36(5). 1195–1211. 34 indexed citations
7.
Mahapatra, Manoj Kumar, Rajnish Kumar, & Manoj Kumar. (2017). Exploring sulfonate esters of 5-arylidene thiazolidine-2,4-diones as PTP1B inhibitors with anti-hyperglycemic activity. Medicinal Chemistry Research. 27(2). 476–487. 23 indexed citations
8.
Mahapatra, Manoj Kumar, et al.. (2017). Validation of TZD Scaffold as Potential ARIs: Pharmacophore Modeling, Atom-based 3D QSAR and Docking Studies. Combinatorial Chemistry & High Throughput Screening. 20(4). 310–320. 1 indexed citations
9.
Mahapatra, Manoj Kumar, Rajnish Kumar, & Manoj Kumar. (2017). N-alkylated thiazolidine-2,4-dione analogs as PTP1B inhibitors: synthesis, biological activity, and docking studies. Medicinal Chemistry Research. 26(6). 1176–1183. 16 indexed citations
10.
Mahapatra, Manoj Kumar, Rajnish Saini, & Manoj Kumar. (2016). Synthesis, anti-hyperglycaemic activity, and in-silico studies of N-substituted 5-(furan-2-ylmethylene)thiazolidine-2,4-dione derivatives. Research on Chemical Intermediates. 42(12). 8239–8251. 8 indexed citations
11.
Aggarwal, Saurabh, Manoj Kumar Mahapatra, Rajnish Kumar, et al.. (2015). Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors. Bioorganic & Medicinal Chemistry. 24(4). 779–788. 13 indexed citations
12.
Kumar, Rajnish, et al.. (2014). Ramping Glucosuria for Management of Type 2 Diabetes Mellitus: An Emerging Cynosure. Medicinal Research Reviews. 34(6). 1146–1167. 9 indexed citations
13.
Mahapatra, Manoj Kumar, Umasankar Kulandaivelu, Philipp Saiko, et al.. (2013). Methyl-2-arylidene hydrazinecarbodithioates: synthesis and biological activity. Chemical Papers. 67(6). 650–656. 11 indexed citations
14.
Mahapatra, Manoj Kumar, et al.. (2013). In silico accounting of novel pyridazine analogues as h-PTP 1B inhibitors: pharmacophore modelling, atom-based 3D QSAR and docking studies. Medicinal Chemistry Research. 23(6). 2701–2711. 7 indexed citations
15.
Kumar, Rajnish, et al.. (2013). A paradigm for development of novel PTP 1B inhibitors: Pharmacophore modelling, atom-based 3D-QSAR and docking studies. Medicinal Chemistry Research. 23(2). 927–938. 5 indexed citations
16.
Mahapatra, Manoj Kumar, Samiye Yabanoğlu, Gülberk Uçar, et al.. (2010). Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies. Bioorganic & Medicinal Chemistry. 18(5). 1875–1881. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026